These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6155132)

  • 1. A specific, fluorescent activity staining procedure applied to plasma and red blood cells in congenital factor XIII deficiency.
    Henriksson P; Stenberg P; Nilsson IM; Rasovic N; Kezic J; Stenbjerg S
    Br J Haematol; 1980 Jan; 44(1):141-7. PubMed ID: 6155132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reversed activity staining procedure for detection of an acquired antibody against factor XIII in a girl with factor XIII deficiency.
    Seiving B; Henriksson P; Stenberg P; Nilsson IM
    Br J Haematol; 1992 Oct; 82(2):414-6. PubMed ID: 1419823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transamidating enzymes in maternal plasma and placenta in human pregnancies complicated by intrauterine growth retardation.
    Persson BL; Stenberg P; Holmberg L; Astedt B
    J Dev Physiol; 1980; 2(1-2):37-46. PubMed ID: 6108341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of factor XIII by SDS polyacrylamide gel electrophoresis.
    Godal HC; Gravem K; Brosstad F; Nyvold N
    Thromb Res; 1984 Sep; 35(5):577-82. PubMed ID: 6484899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid and specific fluorescent activity staining procedure for transamidating enzymes.
    Stenberg P; Stenflo J
    Anal Biochem; 1979 Mar; 93(2):445-52. PubMed ID: 88907
    [No Abstract]   [Full Text] [Related]  

  • 6. A fluorescent spot test for coagulation factor XIII.
    Coggan M; Board PG
    Anal Biochem; 1984 Mar; 137(2):402-4. PubMed ID: 6731823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization and characteristics of transglutaminase in the rabbit and human eye.
    Samuelsson B; Stenberg P; Pandolfi M
    Graefes Arch Clin Exp Ophthalmol; 1982; 218(5):233-6. PubMed ID: 6178650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphism of the A subunit of human coagulation factor XIII.
    Board PG
    Am J Hum Genet; 1979 Mar; 31(2):116-24. PubMed ID: 88180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The subunit composition of factor XIII proteins in normal and factor XIII deficient plasma and serum analysed by line immunoelectrophoresis.
    Krøll J
    Clin Chim Acta; 1989 Feb; 179(3):279-84. PubMed ID: 2714001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrin cross-linking in congenital factor XIII deficiency.
    Rodeghiero F; Barbui T
    J Clin Pathol; 1980 May; 33(5):434-7. PubMed ID: 7400341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic heterogeneity of factor XIII deficiency: first description of unstable A subunits.
    Castle S; Board PG; Anderson RA
    Br J Haematol; 1981 Jun; 48(2):337-42. PubMed ID: 7236530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic determination of blood coagulation Factor XIII in plasma.
    Muszbek L; Polgár J; Fésüs L
    Clin Chem; 1985 Jan; 31(1):35-40. PubMed ID: 2856900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of fibrin stabilization to clot strength. Supplementation of factor XIII-deficient plasma with the purified zymogen.
    Shen L; Lorand L
    J Clin Invest; 1983 May; 71(5):1336-41. PubMed ID: 6853717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proceedings: Determination of Factor XIII (fibrin-stabilizing factor) in plasma and blood platelets].
    Ballerini G; Franceschini F; Guerra S; Meduri P; Scagliarini F
    Quad Sclavo Diagn; 1973 Mar; 9(1):497-581. PubMed ID: 4210088
    [No Abstract]   [Full Text] [Related]  

  • 15. High-performance liquid chromatographic assay of transglutaminase and its application to the purification of human erythrocyte transglutaminase and platelet factor XIII.
    Ando Y; Imamura S; Yamagata Y; Kikuchi T; Murachi T; Kannagi R
    J Biochem; 1987 Jun; 101(6):1331-7. PubMed ID: 2889725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New colored and fluorescent amine substrates for activated fibrin stabilizing factor (Factor XIIIa) and for transglutaminase.
    Lorand L; Parameswaran KN; Velasco PT; Hsu LK; Siefring GE
    Anal Biochem; 1983 Jun; 131(2):419-25. PubMed ID: 6193738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit a antigen and transglutaminase activity.
    Muszbek L; Adány R; Kávai M; Boda Z; Lopaciuk S
    Thromb Haemost; 1988 Apr; 59(2):231-5. PubMed ID: 2898817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding disorder with abnormal wound healing, acid-soluble clots and normal factor XIII.
    Ragaz S; Kemp G; Furlan M; Beck EA
    Thromb Haemost; 1976 Dec; 36(3):537-41. PubMed ID: 1037151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An electrophoretic and quantitative analysis of coagulation factor XIII in normal and deficient subjects.
    Board PG; Coggan M; Hamer JW
    Br J Haematol; 1980 Aug; 45(4):633-40. PubMed ID: 7426441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroimmunoassay of plasma subunits-a and -s in a case of congenital fibrin stabilizing factor deficiency.
    Barbui T; Cartei G; Chisesi T; Dini E
    Thromb Diath Haemorrh; 1974 Sep; 32(1):124-31. PubMed ID: 4454035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.